Top Page
SciDev Ltd
(Sydney:SDV)
SciDev Ltd (SDV) vs. S&P 500 (SPY)
SciDev Ltd Business Overview & Revenue Model
SciDev Ltd Financial Statement Overview
| Breakdown | ||||
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 109.09M | 89.72M | 55.60M | 42.52M | 17.91M | Gross Profit |
| 33.97M | 6.83M | 3.69M | 1.37M | -476.31K | EBIT |
| 4.62M | 456.00K | -479.00K | -513.47K | -2.89M | EBITDA |
| 7.65M | 3.92M | 1.13M | 1.88M | -1.86M | Net Income Common Stockholders |
| 2.17M | -339.00K | -616.00K | 3.45M | -875.24K |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 9.43M | 7.73M | 14.06M | 7.01M | 4.48M | Total Assets |
| 72.01M | 67.37M | 71.16M | 56.15M | 27.17M | Total Debt |
| 5.13M | 3.48M | 2.90M | 5.13M | 538.35K | Net Debt |
| -4.30M | -4.25M | -11.17M | -1.88M | -3.94M | Total Liabilities |
| 21.78M | 19.35M | 22.32M | 24.54M | 9.76M | Stockholders Equity |
| 50.24M | 48.02M | 48.84M | 31.61M | 17.41M |
| Cash Flow | Free Cash Flow | |||
| 4.48M | 522.00K | -3.83M | -1.92M | -1.05M | Operating Cash Flow |
| 6.48M | 4.81M | -1.31M | -1.32M | -177.47K | Investing Cash Flow |
| -3.71M | -8.39M | -6.65M | -2.49M | -1.79M | Financing Cash Flow |
| -1.06M | -2.83M | 14.99M | 6.34M | 4.70M |
SciDev Ltd Technical Analysis
SciDev Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | AU$609.04M | 13.12 | 7.28% | 4.37% | 19.01% | -34.62% | |
68 Neutral | AU$630.31M | 97.63 | 11.59% | ― | 9.76% | -28.92% | |
65 Neutral | AU$70.33M | 35.19 | 4.12% | ― | 20.25% | ― | |
59 Neutral | $7.79B | 153.13 | 2.27% | ― | -20.07% | -74.91% | |
53 Neutral | $9.63M | ― | ― | 3.26% | -800.00% | ||
49 Neutral | $1.95B | -1.21 | -21.28% | 3.72% | 1.18% | -30.47% | |
47 Neutral | $2.22B | ― | -21.31% | ― | ― | ― |
SciDev Ltd Corporate Events
SciDev Limited reported a solid Q3 FY25 performance, with a 10% increase in revenue to $26.3 million and a 200% rise in EBITDA to $2.1 million, despite volatile market conditions. The company expanded its market share in the US Oil & Gas sector and secured significant contracts, including a PFAS remediation project for the US Department of Defence. While client-driven delays may shift some revenues to FY26, the demand for SciDev’s proprietary chemistry remains strong, supporting improved margins. The company is well-positioned to capitalize on the growing demand for sustainable water treatment solutions, with a healthy business development pipeline across all units.
SciDev Ltd has announced significant changes to its board composition, with Mike Utsler appointed as the new Chairman, effective April 1, 2025. This change is part of a strategic move to guide the company through its next growth phase. Additionally, CEO Sean Halpin will transition to the role of Managing Director, following the resolution of conflicts of interest related to a previous acquisition. The board also welcomes Johannes Risseeuw as a Non-Executive Director, replacing Jon Gourlay, who will retire later in the year. These changes are expected to strengthen SciDev’s leadership and support its long-term growth objectives.
SciDev Ltd has secured its first contract in the United States for PFAS remediation, partnering with consulting firm Halff to treat PFAS-contaminated water at US Department of Defense sites. This A$396K contract involves treating up to 190,000 liters of contaminated water across four installations in the Southern US, marking a significant milestone in SciDev’s expansion into the US water technology market. The contract opens up a substantial market opportunity for SciDev, as the US PFAS remediation market is valued at USD $220 billion, with 55,000 identified sites requiring treatment. This development underscores the critical role of SciDev’s proprietary solutions in addressing environmental challenges and highlights the growing global demand for sustainable water treatment solutions.
SciDev Ltd has announced the issuance of 2,732,919 FY2025 Performance Rights as part of an employee incentive scheme. This move is expected to enhance employee engagement and align their interests with the company’s growth objectives, potentially strengthening SciDev’s position in the competitive technology industry.
SciDev Ltd has announced its 1H FY25 results, highlighting its commitment to solving complex water problems through its innovative solutions. The company has treated over 8 billion litres of PFAS-contaminated water and remediated more than 40 PFAS-impacted sites, reflecting its strong market position and dedication to environmental sustainability. These efforts not only enhance SciDev’s operational capabilities but also strengthen its industry positioning as a leader in water treatment technologies.
SciDev Ltd reported solid financial results for the first half of FY25, with revenue of $49.9 million and a 6% increase in underlying EBITDA. The company achieved strategic wins in Europe, securing contracts for PFAS treatment in Sweden and the UK, and expanded its presence in the US mining market through a joint venture. SciDev’s innovations in specialty chemistry have strengthened its position in the US Oil & Gas sector, with successful trials and new product developments. The company continues to leverage its expertise in water treatment, securing multiple contracts and field trials, which are expected to drive future growth.